Diabetes, D-dimer and COVID-19: The possible role of glucose control
- PMID: 33080539
- PMCID: PMC7557166
- DOI: 10.1016/j.dsx.2020.10.011
Diabetes, D-dimer and COVID-19: The possible role of glucose control
Keywords: COVID-19; Cardiovascular disease; Diabetes; Hyperglycemia; Thrombosis.
Conflict of interest statement
Declaration of competing interest Antonio Ceriello does not have conflicts of interest to declare.
References
-
- Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia. 1993;36:1119–1125. - PubMed
-
- Lemkes B.A., Hermanides J., Devries J.H., Holleman F., Meijers J.J.C.M., Hoekstra B.L. Hyperglycemia: a prothrombotic factor? J Thromb Haemostasis. 2010;8:1663–1669. - PubMed
-
- Ceriello A., Giacomello R., Stel G., Motz E., Taboga C., Tonutti L. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes. 1995;44:924–928. - PubMed
-
- Ceriello A., Giugliano D., Quatraro A., Consoli G., Stante A., Dello Russo P. Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes. 1987;36:320–323. - PubMed
-
- Ceriello A., Marchi E., Barbanti M., Milani M.R., Giugliano D., Quatraro A. Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. Diabetologia. 1990;33:205–207. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical